MergerLinks Header Logo

Request Deal Involvement

EcoR1 Capital-backed Panacea Acquisition completed the merger with Nuvation Bio in an $850m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

BMO Capital Markets

financial advisors

BMO Capital Markets

RBC Capital Markets

financial advisors

RBC Capital Markets

Jefferies & Company

financial advisors

Jefferies & Company

Cooley

legal advisors

Cooley

BTIG

financial advisors

BTIG

Wedbush PacGrow

financial advisors

Wedbush PacGrow

W2O Group

pr advisors

W2O Group

Torreya Capital

financial advisors

Torreya Capital

Argot Partners

pr advisors

Argot Partners

TD Cowen

financial advisors

TD Cowen

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Sodali & Co

commercial advisors

Sodali & Co

or

Principals

NUVATION BIO INC

target

NUVATION BIO INC

PANACEA ACQUISITION CORP

bidder

PANACEA ACQUISITION CORP

PAVILION CAPITAL

vendor

PAVILION CAPITAL

AISLING CAPITAL LLC

vendor

AISLING CAPITAL LLC

ALTITUDE LIFE SCIENCE VENTURES

vendor

ALTITUDE LIFE SCIENCE VENTURES

REDMILE GROUP

vendor

REDMILE GROUP

ECOR1 CAPITAL

vendor

ECOR1 CAPITAL

OMEGA FUNDS

vendor

OMEGA FUNDS

PERCEPTIVE ADVISORS LLC

vendor

PERCEPTIVE ADVISORS LLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite